Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017 (2017), Article ID 2608392, 5 pages
https://doi.org/10.1155/2017/2608392
Case Report

Hypercalcemia of Malignancy in Thymic Carcinoma: Evolving Mechanisms of Hypercalcemia and Targeted Therapies

Division of Endocrinology and Metabolism, Rush University Medical Center, Chicago, IL, USA

Correspondence should be addressed to Sanford Baim; ude.hsur@miab_drofnas

Received 15 October 2016; Accepted 19 December 2016; Published 12 January 2017

Academic Editor: Lucy Mastrandrea

Copyright © 2017 Cheng Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Cheng Cheng, Jose Kuzhively, and Sanford Baim, “Hypercalcemia of Malignancy in Thymic Carcinoma: Evolving Mechanisms of Hypercalcemia and Targeted Therapies,” Case Reports in Endocrinology, vol. 2017, Article ID 2608392, 5 pages, 2017. doi:10.1155/2017/2608392